Clinical trials
Withdrawn Substance-Related Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 8 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Children's Hospital | 8 |
| University of Colorado, Denver | 3 |
| Baylor College of Medicine | 2 |
| Canandaigua VA Medical Center | 2 |
| GlaxoSmithKline | 2 |
| Johns Hopkins University | 2 |
| University of California, Los Angeles | 2 |
| University of Florida | 2 |
| Wake Forest University Health Sciences | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Substance-Related Disorders | 67 |
| Alcoholism | 12 |
| Opioid-Related Disorders | 8 |
| Tobacco Use Disorder | 6 |
| Mental Disorders | 5 |
| Anxiety Disorders | 3 |
| Heroin Dependence | 3 |
| Marijuana Abuse | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Alcohol-Related Disorders | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.